Prediction of ventricular arrhythmias using cardiovascular magnetic resonance

European Heart Journal Cardiovascular Imaging

Volumn 14, Issue 6, 2013, Pages 518-525

  Mavrogeni, Sophie ^a   Petrou, Emmanouil ^a   Kolovou, Genovefa ^a   Theodorakis, George ^a   Iliodromitis, Efstathios ^b  

^a ONASSIS CARDIAC SURGERY CENTER   (Greece)

^b NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

Author keywords

Cardiac magnetic resonance; Sudden death; Ventricular arrhythmia

Indexed keywords

ARRHYTHMOGENESIS; ARTICLE; CARDIAC RESYNCHRONIZATION THERAPY; CARDIOVASCULAR MAGNETIC RESONANCE; CHAGAS DISEASE; CONGESTIVE CARDIOMYOPATHY; HEART LEFT VENTRICLE OUTFLOW TRACT; HEART MUSCLE BIOPSY; HEART RIGHT VENTRICLE OUTFLOW TRACT; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE TACHYCARDIA; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; NONISCHEMIC CARDIOMYOPATHY; PREDICTION; PRIORITY JOURNAL; PULMONARY VALVE INSUFFICIENCY; SENSITIVITY AND SPECIFICITY; TAKOTSUBO CARDIOMYOPATHY; VIRUS MYOCARDITIS;

CARDIAC MAGNETIC RESONANCE; SUDDEN DEATH; VENTRICULAR ARRHYTHMIA;

CARDIOMYOPATHY, HYPERTROPHIC; DEATH, SUDDEN, CARDIAC; FEMALE; GADOLINIUM; HUMANS; IMAGE ENHANCEMENT; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE IMAGING, CINE; MALE; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; TACHYCARDIA, VENTRICULAR;

EID: 84877945837     PISSN: 20472404     EISSN: None     Source Type: Journal    
DOI: 10.1093/ehjci/jes302     Document Type: Article

References (77)

1. Zipes DP, Camm AJ, Borggrefe M, Buxton AE, Chaitman B, Fromer M et al. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death). J Am Coll Cardiol 2006;48: e247-e346. (Pubitemid 44382683)
2. Myerburg RJ, Kessler KM, Castellanos A. Sudden cardiac death. Structure, function, and time-dependence of risk. Circulation 1992;85:I2-10.
3. Smith T, Theuns DA, Caliskan K, Jordaens L. Long-term follow-up of prophylactic implantable cardioverter-defibrillator-only therapy: comparison of ischemic and nonischemic heart disease. Clin Cardiol 2011;34:761-7.
4. O'Mahony C, Lambiase PD, Quarta G, Cardona M, Calcagnino M, Tsovolas K et al. The long-term survival and the risks and benefits of implantable cardioverter defibrillators in patients with hypertrophic cardiomyopathy. Heart 2012;98: 116-25.
5. Kreuz J, Horlbeck F, Hoyer F, Mellert F, Fimmers R, Lickfett L et al. An impaired renal function: a predictor of ventricular arrhythmias and mortality in patients with nonischemic cardiomyopathy and heart failure. Pacing Clin Electrophysiol 2011;34:894-9.
6. Buxton AE, Lee KL, Hafley GE, Pires LA, Fisher JD, Gold MR et al. MUSTT Investigators. Limitations of ejection fraction for prediction of sudden death risk in patients with coronary artery disease: lessons from the MUSTT study. J Am Coll Cardiol 2007;50:1150-7. (Pubitemid 47375017)
7. Kalahasti V, Nambi V, Martin DO, Lam CT, Yamada D, Wilkoff BL et al. QRS duration and prediction of mortality in patients undergoing risk stratification for ventricular arrhythmias. Am J Cardiol 2003;92:798-803. (Pubitemid 37163573)
8. Vermes E, Carbone I, Friedrich MG, Merchant N. Patterns of myocardial late enhancement: typical and atypical features. Arch Cardiovasc Dis 2012;105:300-8.
9. Klem I, Weinsaft JW, Bahnson TD, Hegland D, Kim HW, Hayes B et al. Assessment of myocardial scarring improves risk stratification in patients evaluated for cardiac defibrillator implantation. J Am Coll Cardiol 2012;60:408-20.
10. Zipes DP, Camm AJ, Borggrefe M, Buxton AE, Chaitman B, Fromer M et al. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association task force and the European Society of Cardiology committee for practice guidelines (writing committee to develop guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death): developed in collaboration with the European heart rhythm association and the heart rhythm society. Circulation 2006;114:e385-e484.
11. Scrutinio D, Lagioia R, Ricci A, Clemente M, Boni L, Rizzon P. Prediction of mortality in mild to moderately symptomatic patients with left ventricular dysfunction. The role of the New York Heart Association classification, cardiopulmonary exercise testing, two-dimensional echocardiography and Holter monitoring. Eur Heart J 1994;15:1089-95.
12. Assomull RG, Prasad SK, Lyne J, Smith G, Burman ED, Khan M et al. Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy. J Am Coll Cardiol 2006;48:1977-85, 27-29.
13. White JA, Fine NM, Gula L, Yee R, Skanes A, Klein G et al. Utility of cardiovascular magnetic resonance in identifying substrate for malignant ventricular arrhythmias. Circ Cardiovasc Imaging 2012;5:12-20.
14. Krahn AD, Healey JS, Chauhan V, Birnie DH, Simpson CS, Champagne J et al. Systematic assessment of patients with unexplained cardiac arrest: cardiac arrest survivors with preserved ejection fraction registry (casper). Circulation 2009;120: 278-85.
15. Bello D, Fieno DS, Kim RJ, Pereles FS, Passman R, Song G et al. Infarct morphology identifies patients with substrate for sustained ventricular tachycardia. J Am Coll Cardiol 2005;45:1104-8. (Pubitemid 40432446)
16. White JA, Patel MR. The role of cardiovascular MRI in heart failure and the car-diomyopathies. Cardiol Clin 2007;25:71-95. (Pubitemid 46661974)
17. Tandri H, Castillo E, Ferrari VA, Nasir K, Dalal D, Bomma C et al. Magnetic resonance imaging of arrhythmogenic right ventricular dysplasia: sensitivity, specificity, and observer variability of fat detection versus functional analysis of the right ventricle. J Am Coll Cardiol 2006;48:2277-84. (Pubitemid 44855415)
18. Maron MS. Clinical utility of cardiovascular magnetic resonance in hypertrophic cardiomyopathy. J Cardiovasc Magn Reson 2012;14:13.
19. Moon JC, McKenna WJ, McCrohon JA, Elliott PM, Smith GC, Pennell DJ. Toward clinical risk assessment in hypertrophic cardiomyopathy with gadolinium cardiovascular magnetic resonance. J Am Coll Cardiol 2003;41:1561-7. (Pubitemid 36543376)
20. Greulich S, Schumm J, Grün S, Bruder O, Sechtem U, Mahrholdt H. Incremental value of late gadolinium enhancement for management of patients with hyper-trophic cardiomyopathy. Am J Cardiol 2012;110:1207-12.
21. Green JJ, Berger JS, Kramer CM, Salerno M. Prognostic value of late gadolinium enhancement in clinical outcomes for hypertrophic cardiomyopathy. JACC Cardio-vasc Imaging 2012;5:370-7.
22. Fluechter S, Kuschyk J, Wolpert C, Doesch C, Veltmann C, Haghi D et al. Extent of late gadolinium enhancement detected by cardiovascular magnetic resonance correlates with the inducibility of ventricular tachyarrhythmia in hypertrophic car-diomyopathy. J Cardiovasc Magn Reson 2010;12:30.
23. Bruder O, Wagner A, Jensen CJ, Schneider S, Ong P, Kispert EM et al. Myocardial scar visualized by cardiovascular magnetic resonance imaging predicts major adverse events in patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 2010;56:875-87.
24. O'Hanlon R, Grasso A, Roughton M, Moon JC, Clark S, Wage R et al. Prognostic significance of myocardial fibrosis in hypertrophic cardiomyopathy. J Am Coll Cardiol 2010;56:867-74.
25. Appelbaum E, Maron BJ, Adabag S, Hauser TH, Lesser JR, Haas TS et al. Intermediate-signal-intensity late gadolinium enhancement predicts ventricular tachyarrhythmias in patients with hypertrophic cardiomyopathy. Circ Cardiovasc Imaging 2012;5:78-85.
26. Gao P, Yee R, Gula L, Krahn AD, Skanes A, Leong-Sit P et al. Prediction of arrhythmic events in ischemic and dilated cardiomyopathy patients referred for implantable cardiac defibrillator: evaluation of multiple scar quantification measures for late gadolinium enhancement magnetic resonance imaging. Circ Cardio-vasc Imaging 2012;5:448-56.
27. Fernández-Armenta J, Berruezo A, Mont L, Sitges M, Andreu D, Silva E et al. Use of myocardial scar characterization to predict ventricular arrhythmia in cardiac resynchronization therapy. Europace 2012;14:1578-86 [Epub ahead of print].
28. Hombach V, Merkle N, Torzewski J, Kraus JM, Kunze M, Zimmermann O et al. Electrocardiographic and cardiac magnetic resonance imaging parameters as predictors of a worse outcome in patients with idiopathic dilated cardiomyopathy. Eur Heart J 2009;30:2011-8.
29. Nazarian S, Bluemke DA, Lardo AC, Zviman MM, Watkins SP, Dickfeld TL et al. Magnetic resonance assessment of the substrate for inducible ventricular tachycardia in nonischemic cardiomyopathy. Circulation 2005;112:2821-5. (Pubitemid 41641676)
30. Corrado D, Basso C, Thiene G, McKenna WJ, Davies MJ, Fontaliran F et al. Spectrum of clinicopathologic manifestations of arrhythmogenic right ventricular car-diomyopathy/dysplasia: a multicenter study. J Am Coll Cardiol 1997;30:1512-20. (Pubitemid 27486470)
31. McKenna WJ, Thiene G, Nava A, Fontaliran F, Blomstrom-Lundqvist C, Fontaine G et al. Diagnosis of arrhythmogenic right ventricular dysplasia/cardio-myopathy. Task Force of the Working Group Myocardial and Pericardial Disease of the European Society of Cardiology and of the Scientific Council on Cardiomyopathies of the International Society and Federation of Cardiology. Br Heart J 1994;71:215-8.
32. Mavrogeni S, Bratis K, Protonotarios N, Tsatsopoulou A, Papadopoulos G. Cardiac magnetic resonance can early assess the presence and severity of heart involvement in Naxos disease. Int J Cardiol 2012;154:e19-20.
33. Jain A, Tandri H, Calkins H, Bluemke DA. Role of cardiovascular magnetic resonance imaging in arrhythmogenic right ventricular dysplasia. J Cardiovasc Magn Reson 2008;10:32.
34. Sen-Chowdhry S, Syrris P, Ward D, Asimaki A, Sevdalis E, McKenna WJ. Clinical and genetic characterization of families with arrhythmogenic right ventricular dys-plasia/cardiomyopathy provides novel insights into patterns of disease expression. Circulation 2007;115:1710-20. (Pubitemid 46648607)
35. Andreu D, Berruezo A, Ortiz-Pérez JT, Silva E, Mont L, Borràs R et al. Integration of 3D electroanatomic maps and magnetic resonance scar characterization into the navigation system to guide ventricular tachycardia ablation. Circ Arrhythm Elec-trophysiol 2011;4:674-83.
36. Mavrogeni S, Spargias K, Bratis C, Kolovou G, Papadopoulou E, Pavlides G. EBV infection as a cause of vt: evaluation by CMR. JACC Cardiovasc Imaging 2011;4: 561-2.
37. Monney PA, Sekhri N, Burchell T, Knight C, Davies C, Deaner A et al. Acute myocarditis presenting as acute coronary syndrome: role of early cardiac magnetic resonance in its diagnosis. Heart 2011;97:1312-8.
38. Grün S, Schumm J, Greulich S, Wagner A, Schneider S, Bruder O et al. Long-term follow-up of biopsy-proven viral myocarditis: predictors of mortality and incomplete recovery. J Am Coll Cardiol 2012;59:1604-15.
39. Drago F, Mazza A, Gagliardi MG, Bevilacqua M, Di Renzi P, Calzolari A et al. Tachycardias in children originating in the right ventricular outflow tract: lack of clinical features predicting the presence and severity of the histopathological substrate. Cardiol Young 1999;9:273-9.
40. de Mello RP, Szarf G, Schvartzman PR, Nakano EM, Espinosa MM, Szejnfeld D et al. Delayed enhancement cardiac magnetic resonance imaging can identify the risk for ventricular tachycardia in chronic Chagas' heart disease. Arq Bras Cardiol 2012;98:421-30.
41. Aletras AH, Tilak GS, Natanzon A, Hsu LY, Gonzalez FM, Hoyt RF Jr et al. Retrospective determination of the area at risk for reperfused acute myocardial infarction with T2-weighted cardiac magnetic resonance imaging: histopathologic-al and displacement encoding with stimulated echoes (DENSE) functional validations. Circulation 2006;113:1865-70. (Pubitemid 43739398)
42. Roes SD, Kelle S, Kaandorp TA, Kokocinski T, Poldermans D, Lamb HJ et al. Comparison of myocardial infarct size assessed with contrast-enhanced magnetic resonance imaging and left ventricular function and volumes to predict mortality in patients with healed myocardial infarction. Am J Cardiol 2007;100:930-6. (Pubitemid 47368098)
43. Kelle S, Roes SD, Klein C, Kokocinski T, de Roos A, Fleck E et al. Prognostic value of myocardial infarct size and contractile reserve using magnetic resonance imaging. J Am Coll Cardiol 2009;54:1770-7.
44. Catalano O, Moro G, Perotti M, Frascaroli M, Ceresa M, Antonaci S et al. Late gadolinium enhancement by cardiovascular magnetic resonance is complementary to left ventricle ejection fraction in predicting prognosis of patients with stable coronary artery disease. J Cardiovasc Magn Reson 2012;14:29.
45. Schelbert EB, Cao JJ, Sigurdsson S, Aspelund T, Kellman P, Aletras AH et al. Prevalence and prognosis of unrecognized myocardial infarction determined by cardiac magnetic resonance in older adults. JAMA 2012;308:890-6.
46. Boyé P, Abdel-Aty H, Zacharzowsky U, Bohl S, Schwenke C, van der Geest RJ et al. Prediction of life-threatening arrhythmic events in patients with chronic myocardial infarction by contrast-enhanced CMR. JACC Cardiovasc Imaging 2011; 4:871-9.
47. de Haan S, Meijers TA, Knaapen P, Beek AM, van Rossum AC, Allaart CP. Scar size and characteristics assessed by CMR predict ventricular arrhythmias in is-chaemic cardiomyopathy: comparison of previously validated models. Heart 2011;97:1951-6.
48. Kwon DH, Halley CM, Carrigan TP, Zysek V, Popovic ZB, Setser R et al. Extent of left ventricular scar predicts outcomes in ischemic cardiomyopathy patients with significantly reduced systolic function: a delayed hyperenhancement cardiac magnetic resonance study. JACC Cardiovasc Imaging 2009;2:34-44.
49. Kwong RY, Chan AK, Brown KA, Chan CW, Reynolds HG, Tsang S et al. Impact of unrecognized myocardial scar detected by cardiac magnetic resonance imaging on event-free survival in patients presenting with signs or symptoms of coronary artery disease. Circulation 2006;113:2733-43. (Pubitemid 43947991)
50. de Luna AB, Coumel P, Leclercq JF. Ambulatory sudden cardiac death: mechanisms of production of fatal arrhythmia on the basis of data from 157 cases. Am Heart J 1989;117:151-9. (Pubitemid 19043766)
51. Solomon SD, Zelenkofske S, McMurray JJV, Finn PV, Velazquez E, Ertl G et al. The Valsartan in Acute Myocardial Infarction Trial I. Sudden death in patients with myocardial infarction and left ventricular dysfunction, heart failure, or both. N Engl J Med 2005;352:25818.
52. Mozaffarian D, Anker SD, Anand I, Linker DT, Sullivan MD, Cleland JG et al. Prediction of mode of death in heart failure: the Seattle Heart Failure Model. Circulation 2007;116:392-8. (Pubitemid 47196544)
53. Bello D, Fieno DS, Kim RJ. Infarct morphology identifies patients with substrate for sustained ventricular tachycardia. J Am Coll Cardiol 2005;45:1104-8. (Pubitemid 40432446)
54. Bolick D, Hackel D, Reimer K, Ideker R. Quantitative analysis of myocardial infarct structure in patients with ventricular tachycardia. Circulation 1986;74:1266-79. (Pubitemid 17189246)
55. Miller JM, Harken AH, Hargrove WC, Josephson ME. Pattern of endocardial activation during sustained ventricular tachycardia. J Am Coll Cardiol 1985;6:1280-7. (Pubitemid 16171974)
56. de Bakker JM, van Capelle FJ, Janse MJ, Wilde AA, Coronel R, Becker AE et al. Reentry as a cause of ventricular tachycardia in patients with chronic ischemic heart disease: electrophysiologic and anatomic correlation. Circulation 1988;77:589-606. (Pubitemid 18073351)
57. Scott PA, Morgan JM, Carroll N, Murday DC, Roberts PR, Peebles CR et al. The extent of left ventricular scar quantified by late gadolinium enhancement MRI is associated with spontaneous ventricular arrhythmias in patients with coronary artery disease and implantable cardioverter-defibrillators. Circ Arrhythm Electrophy-siol 2011;4:324-30.
58. Schuleri KH, Centola M, Evers KS, Zviman A, Evers R, Lima JA et al. Cardiovascular magnetic resonance characterization of peri-infarct zone remodeling following myocardial infarction. J Cardiovasc Magn Reson 2012;14:24.
59. Schmidt A, Azevedo CF, Cheng A, Gupta SN, Bluemke DA, Foo TK et al. Infarct tissue heterogeneity by magnetic resonance imaging identifies enhanced cardiac arrhythmia susceptibility in patients with left ventricular dysfunction. Circulation 2007;115:2006-14. (Pubitemid 46625951)
60. Yan AT, Shayne AJ, Brown KA, Gupta SN, Chan CW, Luu TM et al. Characterization of the peri-infarct zone by contrast-enhanced cardiac magnetic resonance imaging is a powerful predictor of post-myocardial infarction mortality. Circulation 2006;114:32-9. (Pubitemid 44305272)
61. Roes SD, Borleffs CJ, van der Geest RJ, Westenberg JJ, Marsan NA, Kaandorp TA et al. Infarct tissue heterogeneity assessed with contrast-enhanced MRI predicts spontaneous ventricular arrhythmia in patients with ischemic cardiomyopathy and implantable cardioverter-defibrillator. Circ Cardiovasc Imaging 2009;2:183-90.
62. Kotu LP, Engan K, Eftestøl T, Ørn S, Woie L. Segmentation of scarred and non-scarred myocardium in LG enhanced CMR images using intensity-based textural analysis. Conf Proc IEEE Eng Med Biol Soc 2011;2011:5698-701.
63. Woie L, Eftestøl T, Engan K, Kvaløy JT, Nilsen DW, Ørn S. The heart rate of ventricular tachycardia following an old myocardial infarction is inversely related to the size of scarring. Europace 2011;13:864-8.
64. Ashikaga H, Sasano T, Dong J, Zviman MM, Evers R, Hopenfeld B et al. Magnetic resonance-based anatomical analysis of scar-related ventricular tachycardia: implications for catheter ablation. Circ Res 2007;101:939-47. (Pubitemid 350287181)
65. Messroghli DR, Walters K, Plein S, Sparrow P, Friedrich MG, Ridgway JP et al. Myocardial T1 mapping: application to patients with acute and chronic myocardial infarction. Magn Reson Med 2007;58:34-40. (Pubitemid 47229915)
66. Maceira AM, Joshi J, Prasad SK, Moon JC, Perugini E, Harding I et al. Cardiovascular magnetic resonance in cardiac amyloidosis. Circulation 2005;111:186-93. (Pubitemid 40139730)
67. Dall'Armellina E, Piechnik SK, Ferreira VM, Si QL, Robson MD, Francis JM et al. Cardiovascular magnetic resonance by non contrast T1-mapping allows assessment of severity of injury in acute myocardial infarction. J Cardiovasc Magn Reson 2012;14:15.
68. Ugander M, Bagi PS, Oki AJ, Chen B, Hsu LY, Aletras AH et al. Myocardial edema as detected by pre-contrast T1 and T2 CMR delineates area at risk associated with acute myocardial infarction. JACC Cardiovasc Imaging 2012;5:596-603.
69. Tsai SF, Chan DP, Ro PS, Boettner B, Daniels CJ. Rate of inducible ventricular arrhythmia in adults with congenital heart disease. Am J Cardiol 2010;106: 730-6.
70. Van Aerschot I, Iserin L. Follow-up of tetralogy of Fallot after repair. Presse Med 2011;40:740-7.
71. Folino AF, Daliento L. Arrhythmias after tetralogy of fallot repair. Indian Pacing Electrophysiol J 2005;5:312-24. (Pubitemid 41581984)
72. Ortega M, Triedman JK, Geva T, Harrild DM. Relation of left ventricular dyssyn-chrony measured by cardiac magnetic resonance tissue tracking in repaired tetralogy of fallot to ventricular tachycardia and death. Am J Cardiol 2011;107:1535-40.
73. Therrien J, Siu SC, Harris L, Dore A, Niwa K, Janousek J et al. Impact of pulmonary valve replacement on arrhythmia propensity late after repair of tetralogy of Fallot. Circulation 2001;103:2489-94. (Pubitemid 32493376)
74. Wald RM, Haber I, Wald R, Valente AM, Powell AJ, Geva T. Effects of regional dysfunction and late gadolinium enhancement on global right ventricular function and exercise capacity in patients with repaired tetralogy of Fallot. Circulation 2009; 119:1370-7.
75. Knauth AL, Gauvreau K, Powell AJ, Landzberg MJ, Walsh EP, Lock JE et al. Ventricular size and function assessed by cardiac MRI predict major adverse clinical outcomes late after tetralogy of Fallot repair. Heart 2008;94:211-6. (Pubitemid 351211733)
76. Babu-Narayan SV, Kilner PJ, Li W, Moon JC, Goktekin O, Davlouros PA et al. Ventricular fibrosis suggested by cardiovascular magnetic resonance in adults with repaired tetralogy of fallot and its relationship to adverse markers of clinical outcome. Circulation 2006;113:405-13. (Pubitemid 43803202)
77. Babu-Narayan SV, Goktekin O, Moon JC, Broberg CS, Pantely GA, Pennell DJ et al. Late gadolinium enhancement cardiovascular magnetic resonance of the systemic right ventricle in adults with previous atrial redirection surgery for transposition of the great arteries. Circulation 2005;111:2091-8. (Pubitemid 40577904)